Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Mouse Anti-Porcine Toll-Like Receptor 5 (TLR5) Monoclonal Antibody

Cat. No.VD10N203

Product TypeAnimal-targeted Antibodies

Size 100ug

Product Overview

BioVenic mouse monoclonal antibody is specific for toll-like receptor 5. It is affinity purified by protein G. It can be applied to WB, IF, IHC, Indirect ELISA assays of toll-like receptor 5.

Specifications

Application ELISA; IF/ICC; WB
Clonality Monoclonal
Classification Primary Antibody
Clone O13N51
Host Mouse
Target Species Porcine
Species Reactivity Porcine
Specificity Toll-Like Receptor 5
Isotype IgG1
Immunogen Recombinant protein of toll-like receptor 5
Purification Protein G Purified
Concentration 1mg/mL
Conjugation Unconjugated
Buffer Phosphate Buffered Saline
Physical State Liquid

Target Information

Porcine toll-like receptor 5 (TLR5) is a key pattern recognition receptor that plays a crucial role in the innate immune system. TLR5 is primarily recognized for its ability to detect bacterial flagellin, a component of bacterial flagella, which is a potent activator of the immune response. The activation of TLR5 by flagellin leads to the initiation of signaling cascades that result in the production of pro-inflammatory cytokines and the recruitment of immune cells to the site of infection.

Target Toll-Like Receptor 5
Gene ID 100144476
UniProt ID Q59HI7

Shipping and Storage

This product is shipped with ice gel packs. Store at -80°C on receipt.

Documents

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

References

  1. Mett, Vadim, et al. "A deimmunized and pharmacologically optimized Toll-like receptor 5 agonist for therapeutic applications." Communications Biology 4.1 (2021): 466.
Inquiry Basket